Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

3 clinical studies listed.

Filters:

Ureteral Stent-Related Symptom

Tundra lists 3 Ureteral Stent-Related Symptom clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

ENROLLING BY INVITATION

NCT06979583

Impact of Ureteral Stent and Sheaths Size on Post-Operative Pain

The purpose of this study is to determine if post-operative stent size impacts stent-related pain and discomfort.

Gender: All

Ages: 18 Years - Any

Updated: 2026-03-06

1 state

Ureteral Stent-Related Symptom
Retrograde Intra-renal Surgery
NOT YET RECRUITING

NCT06930690

Dexamethasone for Ureteral STent Symptoms (DUSTS)

The purpose of this study to learn if high-dose dexamethasone, a type of long-acting steroid, works to decrease urinary symptoms and pain after ureteroscopy and stent placement for kidney stones. The main question it aims to answer is: 1\) Does high-dose steroid change the quality of life score on day 2 after surgery Researchers will compare high-dose of dexamethasone (20 mg) to a standard dose of dexamethasone (4 mg) to see if a higher dose of the drug will help with urinary symptoms and pain Participants will: 1. randomly receive 20 mg or 4 mg of dexamethasone (20 mg) at the time of surgery 2. fill out a questionnaire day 1 and day 2 after surgery 3. fill out a medication diary for one week after surgery 4. visit the clinic on day 2 after surgery for checkup 5. visit the clinic on day 4-7 after surgery for check up

Gender: All

Ages: 18 Years - 70 Years

Updated: 2026-03-05

1 state

Ureteral Stent-Related Symptom
RECRUITING

NCT06803030

Study of Tamsulosin, Solifenacin and Mirabegron in Alleviating Ureteral Stent-related Symptoms

A comparative study on the efficacy of Tamsulosin, Solifenacin and Mirabegron in alleviating ureteral stent-related symptoms: a randomized controlled trial.

Gender: All

Ages: 18 Years - 80 Years

Updated: 2025-09-08

1 state

Ureteral Stent-Related Symptom